Evidence map›Paper›PMID 26398933›Full record

ArticleDisease models & mechanisms2015

A simple method for in vivo labelling of infiltrating leukocytes in the mouse retina using indocyanine green dye.

Dawn A Sim, Colin J Chu, Senthil Selvam, Michael B Powner, Sidath Liyanage, David A Copland, Pearse A Keane, Adnan Tufail, Catherine A Egan, James W B Bainbridge and 3 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Disease models & mechanisms, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Dawn A SimNIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK University College London, Institute of Ophthalmology, London EC1V 9EL, UK.
Colin J ChuUniversity College London, Institute of Ophthalmology, London EC1V 9EL, UK Academic Unit of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol BS8 1TD, UK.
Senthil SelvamNIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK University College London, Institute of Ophthalmology, London EC1V 9EL, UK.
Michael B PownerUniversity College London, Institute of Ophthalmology, London EC1V 9EL, UK.
Sidath LiyanageUniversity College London, Institute of Ophthalmology, London EC1V 9EL, UK.
David A CoplandAcademic Unit of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol BS8 1TD, UK.
Pearse A KeaneNIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK University College London, Institute of Ophthalmology, London EC1V 9EL, UK.
Adnan TufailNIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK University College London, Institute of Ophthalmology, London EC1V 9EL, UK.
Catherine A EganNIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
James W B BainbridgeNIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK University College London, Institute of Ophthalmology, London EC1V 9EL, UK.
Richard W LeeNIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK Academic Unit of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol BS8 1TD, UK.
Andrew D DickNIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK Academic Unit of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol BS8 1TD, UK.
Marcus FruttigerUniversity College London, Institute of Ophthalmology, London EC1V 9EL, UK m.fruttiger@ucl.ac.uk.
University College London · GBMoorfields Eye Hospital · GBMoorfields Eye Hospital NHS Foundation Trust · GBUniversity of Bristol · GB

Funding

Department of Health CS-2014-14-023Department of Health NIHR-RP-011-003Medical Research Council G1100383Medical Research Council MR/K003003/1
6 · The paper itself

Abstract

We have developed a method to label and image myeloid cells infiltrating the mouse retina and choroid in vivo, using a single depot injection of indocyanine green dye (ICG). This was demonstrated using the following ocular models of inflammation and angiogenesis: endotoxin-induced uveitis, experimental autoimmune uveoretinitis and laser-induced choroidal neovascularization model. A near-infrared scanning ophthalmoscope was used for in vivo imaging of the eye, and flow cytometry was used on blood and spleen to assess the number and phenotype of labelled cells. ICG was administered 72 h before the induction of inflammation to ensure clearance from the systemic circulation. We found that in vivo intravenous administration failed to label any leukocytes, whereas depot injection, either intraperitoneal or subcutaneous, was successful in labelling leukocytes infiltrating into the retina. Progression of inflammation in the retina could be traced over a period of 14 days following a single depot injection of ICG. Additionally, bright-field microscopy, spectrophotometry and flow cytometric analysis suggest that the predominant population of cells stained by ICG are circulating myeloid cells. The translation of this approach into clinical practice would enable visualization of immune cells in situ. This will not only provide a greater understanding of pathogenesis, monitoring and assessment of therapy in many human ocular diseases but might also open the ability to image immunity live for neurodegenerative disorders, cardiovascular disease and systemic immune-mediated disorders.

Indexed as

Chemotaxis, LeukocyteAnimalsAutoimmune DiseasesCells, CulturedCell TrackingChoroidChoroidal NeovascularizationDisease Models, AnimalDisease ProgressionEndotoxinsFemaleFluorescein AngiographyFluorescent DyesFreund's AdjuvantHumansIndocyanine GreenEndotoxinsFluorescent DyesFreund's AdjuvantIndocyanine GreenIndocyanine greenInflammationIn vivo imaging

Identifiers

PMID26398933
PMCPMC4631782
OpenAlexW1961712050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.